A Zambian business can have a good product, paying customers and a credible founder, yet still struggle to attract the kind of capital that would allow it to become a larger business.
This is partly a financing problem.
But it is also a problem of time.
Too much capital expects businesses to prove themselves on timelines that do not always match the realities of building a business in Zambia.
A manufacturer needs machinery before it can increase production. An agricultural business may have to wait for a harvest cycle. A technology company may need years to build a reliable customer base. A business serving rural markets may spend more time establishing distribution than one operating entirely in Lusaka.
The economics do not always fit a twelve-month return expectation.
This is where patient capital matters.
Capital has a clock
Every form of finance comes with an implicit clock.
A bank loan has repayment dates. An investor expects growth and eventually a return. A grant has a programme period. A venture capitalist may be working within a fund's investment and exit cycle.
There is nothing inherently wrong with these expectations.
The problem arises when the financing clock is shorter than the business cycle.
A company can be economically viable and still be too early for conventional finance.
That distinction matters.
A business that is not yet generating enough cash to repay a large loan is not necessarily a bad business. It may simply need more time to reach the point where its revenues can support that debt.
Zambia has long investment cycles
This is particularly relevant to Zambia because many productive sectors require patient investment.
Agriculture does not operate according to quarterly reporting cycles. Manufacturing requires investment in equipment, working capital and distribution. Tourism businesses depend on infrastructure, seasons and international demand. Mining projects can take years before substantial production begins.
Even smaller businesses face slower development than investors sometimes assume.
A local software company may need to educate its market before customers understand what it is selling. A small manufacturer may need to establish reliable suppliers before increasing output. A business expanding outside Lusaka may have to build distribution networks almost from scratch.
The initial years can therefore look unimpressive on a spreadsheet while the underlying business is becoming stronger.
The missing middle
Zambia's financing debate often gets framed around whether businesses can access loans or whether entrepreneurs can obtain investment.
There is another question: what kind of capital is available between the two?
Debt can be too rigid for an early-stage company with uneven cash flows.
Equity can be expensive in another way, particularly when founders are asked to surrender substantial ownership before the business has demonstrated its full potential.
Grants can help, but they are usually limited and programme-driven.
Patient capital occupies a different space.
It can take the form of long-term equity, concessional finance, revenue-based financing, subordinated debt, blended finance or other structures designed around the realities of business development.
The important characteristic is not the label.
It is the willingness to wait.
Waiting does not mean ignoring performance
Patient capital should not be confused with careless capital.
A patient investor still needs evidence of progress.
There should be milestones, financial controls, reporting and accountability.
The difference is that performance is measured against a realistic development path rather than an artificial demand for immediate profitability.
That distinction could be particularly important for businesses building productive capacity.
If a company uses capital to purchase equipment, hire workers, develop distribution and enter new markets, its early financial statements may look very different from those of a mature business.
The investor needs to understand what the spending is building.
The development finance opportunity
This is where development finance institutions, pension funds, banks, impact investors and other long-term pools of capital could play an important role in Zambia.
The country does not only need money chasing businesses that are already large and profitable.
It also needs capital willing to help viable businesses cross the distance between small enterprise and established company.
That distance is where many businesses struggle.
They are too established to be treated purely as ideas, but too small, too young or too volatile for conventional commercial finance.
The result is a financing gap.
And financing gaps have economic consequences.
A business that cannot buy equipment cannot increase production. A manufacturer without working capital cannot accept a larger order. A technology company without sufficient runway may abandon product development just as demand begins to emerge.
Capital is therefore not simply financing consumption.
Used well, it finances productive capacity.
Zambia should think beyond the startup
There is also a tendency to associate patient capital with technology startups.
That is too narrow.
A Zambian food processor expanding its production line may need patient capital.
So might an agricultural business investing in irrigation, a manufacturer purchasing machinery or a logistics company expanding its fleet.
These are not necessarily venture-capital businesses.
They are productive businesses.
The financing system should therefore be capable of supporting different forms of growth rather than forcing every enterprise into the same investment model.
The cost of being impatient
There is a broader economic cost when capital becomes too impatient.
Businesses learn to optimise for fundraising rather than production.
Founders prioritise short-term revenue over long-term investment.
Companies avoid sectors where returns take longer.
And investors crowd into businesses that can demonstrate quick financial metrics while neglecting activities that may generate larger economic benefits over a longer period.
That can distort the structure of an economy.
Zambia needs capital that recognises that building productive capacity takes time.
Patient capital is not charity. It is a different assessment of risk, time and value.
The question is whether the country can develop more financial instruments that match the actual rhythm of its businesses.
Because sometimes the problem is not that a business needs more money.
It is that the money available expects the business to become mature before it has had enough time to grow.
